Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95)

Clinical Chemistry

Volumn 44, Issue 3, 1998, Pages 578-585

  Caillot Augusseau, Anne ^b   Lafage Proust, Marie Héléne ^a   Soler, Claude ^b   Pernod, Josiane ^c   Dubois, Francis ^b   Alexandre, Christian ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c LMM Laboratoire Marcel Merieux   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; PARATHYROID HORMONE; PROCOLLAGEN;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE REMODELING; CALCIUM BLOOD LEVEL; COSMONAUT; HUMAN; HUMAN EXPERIMENT; MALE; MICROGRAVITY; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; PROTEIN DETERMINATION; SPACE FLIGHT;

EID: 0031914550     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.3.578     Document Type: Article

References (38)

1. Frost HM. Skeletal structural adaptation to mechanical usage (STMU): 3. Redefining Wolff's law: the remodeling problem. Anat Rec 1990;226:414-22.
2. Whedon GD, Heaney RP. Effects of physical inactivity, paralysis and weightlessness on bone growth. In: Hall BK, ed. Bone, Vol. 7. Bone growth - B. Boca Raton, FL: CRC Press, 1993:57-78.
3. Morey-Holton ER, Cone CM. Bone asa model system for organ/ tissue responses to microgravity. In: Asashima M, Malasinski GM, eds. Fundamentals of space biology. Tokyo: Springer Verlag, 1990:113-22.
4. Vico L, Chappard D, Palle S, Bakulin AV, Novikov VE, Alexandre C. Trabecular bone remodeling after 7 days of weightlessness exposure (BIOCOSMOS 1667). Am J Physiol 1988;255:R242-7.
5. Vico L, Bourrin S, Genty C, Palle S, Alexandre C. Histomorphometric analysis of cancellous bone from COSMOS 2044 rats. J Appl Physiol 1993;75:2203-8.
6. Jee WSS, Wronski TJ, Morey ER, Kimmel DB. Effects of spaceflight on trabecular bone in rats. Am J Physiol 1983;244:R310-4.
7. Morey ER, Baylink DJ. Inhibition of bone formation during space flight. Science 1978;201:1138-41.
8. Whedon GD, Lutwak L, Rambaut PC, Witthle MW, Reid J, Smith MC, et al. Mineral and nitrogen balance study observations, the second manned space Skylab mission. Aviat Space Environ Med 1976;47:391-6.
9. Collet P, Vico L, Alexandre C. Follow-up of weight- and non weight-bearing bone mineral densities at cortical and cancellous levels in cosmonauts. Proceedings of the 18th Annual International Gravitational Physiology Meeting. Norsk Ed, Copenhagen, Denmark, 1997:62.
10. Hauschka PV, Frenkel J, De Muth R, Gunderberg CM. Presence of osteocalcin and related higher molecular weight 4-carboxyglutamic acid containing proteins in developing bone. J Biol Chem 1983;258:176-82.
11. Thiede MA, Smock SL, Petersen DN, Grasser WA, Thompson DD, Nishimooto SK. Presence of mRNA encoding osteocalcin, a marker of bone turnover in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 1994;135:929-37.
12. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64.
13. Delmas PD, Malaval L, Arlot ME, Meunier PL. Serum bone GLA-Protein compared to bone histomorphometry in endocrine diseases. Bone 1985;6:339-41.
14. Howard AD, Berger J, Familletti P, Udenfriend S. Characterization of the phosphatidylinositol-glycan membrane anchor of human placental alkaline phosphatase. Proc Natl Acad Sci U S A 1987; 84:6055-9.
15. Melko S, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990;36:1328-32.
16. Delmas PD, Ginetys E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslinks excretion in normal adults and in Paget's disease. J Bone Miner Res 1993;8:643-8.
17. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994;40:2022-5.
18. Maciewicz RA, Wotton SF, Ethrington DJ, Duance VC. Susceptibility of the cartilage collagen II, IX, and XI to degradation by cysteine proteinases, cathepsins B and L. FEBS Lett 1990;269:189.
19. Garnero P, Gynetys E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
20. Kamel S, Brazier M, Neri V, Picard C, Samson L, Desmet G, Sebert JL. Multiple molecular forms of pyridinoline cross-links excreted in human urine evaluated by chromatographic and immunoassay methods. J Bone Miner Res 1995;9:1385-92.
21. Kamel S, Brazier M, Rogez JC, Vincent O, Maamer M, Desmet G, Sebert JL. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency. J Clin Endocrinol Metab 1996;10: 3717-21.
22. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995;80:864-8.
23. Morey-Holton ER, Schnoes HF, DeLuca HF, Phelps ME, Klein RF, Nissenson RH, Arnaud SB. Vitamin D metabolites and bioactive parathyroid hormone levels during Spacelab 2. Aviat Space Environ Med 1988;59:1038-41.
24. Garnero P, Delmas PD. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone diseases. J Clin Endocrinol Metab 1993;77:1046-53.
25. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64.
26. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res 1992;7: 1389-98.
27. Bondy PK. The adrenal cortex. In: Bondy PK, Rosenberg LE, eds. Metabolic control and disease, 8th ed. Philadelphia: WB Saunders, 1980:1427-99.
28. Morey-Holton ER, et al. Vitamin D metabolites and bioactive PTH levels during space lab 2. Aviat Space Environ Med 1988;59: 1038-41.
29. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993; 25:385-93.
30. Collet P, Uebelhart D, Vico L, Morod L, Hartmann D, Roth M, Alexandre C. Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans. Bone 1997;20:547-51.
31. Haushka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1010.
32. Lafage-Proust MH, Alexandre C, Vico L. Spaceflight-induced cancellous bone loss worsens after earth recovery (American SLS2 mission) [Abstract]. J Bone Miner Res 1996;11:M569, S49.
33. Alexandre C, Vico L, Pilonchery J, Chapuy MC, Delmas PD, Chappard D; Effets de l'apesanteur sur le métabolisme phosphocalcique et sa régulation hormonale chez l'homme au cours du vol spatial francoamericain 51 G. Pathol Biol 1988;36:144-8.
34. Delmas PD. Biochemical markers of bone remodeling. In: Papapoulos et al, eds. Osteoporosis 1996. Amsterdam: Elsevier Science, 1996:191-204.
35. Roux JP, Arlot M, Ginetys E, Meunier PJ, Delmas PD. Automatic measurements of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline. Bone 1995;17:153-6.
36. Robins S, Woitge H, Hesley R, Ju J, Seyedin S, Sliebel MJ. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;10:1643-9.
37. Nakamura H, Tomoko M, Genma R, Suzuki Y, Natsume H, Andoh S, et al. Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism. Clin Endocrinol 1996;44:447-51.
38. Brazier M, Kamel S, Maamer M, Agbomson F, Elesper I, Garabedian M, et al. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction. J Bone Miner Res 1995;11:1753-61.